Trials / Unknown
UnknownNCT06194253
Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment
Evaluation of the Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment Followed by a Return Home
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500,000 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
To date, studies have been carried out on emergency department revisits but most are studies carried out in Anglo-Saxon territories. The studies carried out in France, for their part, concern the elderly geriatric population, or populations with specific pathologies such as child psychiatrists or patients with acute heart failure, but not the general adult population. Nevertheless, these studies have shown that knowledge of the risk factors for early readmission of a patient makes it possible to carry out targeted prevention actions in order to reduce this early recourse rate. However, in a context of increasing emergency flow and increasing tension in the field with limited healthcare resources, returning home and outpatient care are increasingly favored. However, these strategies only make sense if outpatient follow-up is organized when early reconsultation is possible for certain indications that remain to be determined. In this context, it would be interesting to have information on the reasons for which patients return to the emergency room early after initial treatment. This would indeed make it possible to consider carrying out preventive actions in the long term in order to reduce this revisit rate on the one hand and on the other hand to identify the signs of seriousness which should bring the patient back to the emergency room as soon as possible.
Conditions
Timeline
- Start date
- 2023-07-10
- Primary completion
- 2025-07-01
- Completion
- 2025-07-01
- First posted
- 2024-01-08
- Last updated
- 2024-01-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06194253. Inclusion in this directory is not an endorsement.